Amneal Pharmaceuticals, Inc. 10-Q filing
Filed 2025-11-06 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001723128-25-000062
- Form type
- 10-Q
- CIK
- 0001723128
- Primary document
- https://www.sec.gov/Archives/edgar/data/1723128/000172312825000062/amrx-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Amneal Pharmaceuticals, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $2.2B | - | - |
| Cost Of Revenue | $1.4B | - | - |
| Gross Profit | $816.1M | - | - |
| Operating Income | $282.1M | - | - |
| Net Income | $37.0M | - | - |
| Eps Basic | 0.12 | - | - |
| Eps Diluted | 0.11 | - | - |
| Cash And Equivalents | $201.2M | - | - |
| Total Assets | $3.6B | - | - |
| Shareholders Equity | $-109.5M | - | - |
| Operating Cash Flow | $209.7M | - | - |
| Capital Expenditures | $48.3M | - | - |